Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
29.89
+0.59 (2.01%)
At close: Oct 9, 2026, 4:00 PM EDT
30.00
+0.11 (0.37%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Celldex Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $38 → $28 | Hold | Maintains | $38 → $28 | -6.32% | Oct 5, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $56 → $64 | Buy | Maintains | $56 → $64 | +114.12% | Oct 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $64 | Buy | Maintains | $64 | +114.12% | Oct 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $70 → $88 | Buy | Reiterates | $70 → $88 | +194.41% | Sep 23, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $100 | Buy | Reiterates | $100 | +234.56% | Sep 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $60 | Buy | Reiterates | $60 | +100.74% | Sep 23, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $58 → $68 | Buy | Reiterates | $58 → $68 | +127.50% | Sep 23, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $72 | Buy | Reiterates | $72 | +140.88% | Sep 23, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.